Wondfo USA Co., Ltd.

Wondfo USA Co., Ltd. is a manufacturer of point-of-care diagnostic tests headquartered in Bolingbrook, Illinois, with a research and manufacturing center in San Diego. Founded in 2009, the company has served the North American market for over 15 years, specializing in rapid diagnostic and chronic disease management solutions. The company manufactures and distributes point-of-care tests across four major product categories: Toxicology Testing, Infectious Disease, Women's Reproductive Health, and Veterinary Diagnostics. Key product lines include the WELLlife™ series (COVID-19, influenza, and combined respiratory tests), SAFElife™ (workplace drug testing including hair-based and urine tests with fentanyl detection), HORMONElife™ (reproductive health and fertility tracking), and PETlife™ (veterinary fertility testing). The company holds FDA 510(k) clearances for multiple products, including the WELLlife™ Flu A&B Test and WELLlife™ COVID-19/Influenza A&B combined test. Products are also authorized for distribution by Health Canada. Wondfo manufactures cassette and dip-card format rapid tests, with associated mobile applications for data tracking and result management. The company serves healthcare providers, diagnostic laboratories, occupational health programs, and consumer markets with both over-the-counter and clinical-use tests.